These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2514474

  • 21. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML, Coelho PM, Antunes CM, Tavares CA, da Cunha AS.
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [Abstract] [Full Text] [Related]

  • 22. Schistosomiasis mansoni in Burundi: progress in its control since 1985.
    Engels D, Ndoricimpa J, Gryseels B.
    Bull World Health Organ; 1993; 71(2):207-14. PubMed ID: 8490984
    [Abstract] [Full Text] [Related]

  • 23. Effects of praziquantel and oxamniquine on a Saudi Arabian strain of Schistosoma mansoni in mice.
    Ghandour AM, Banaja AA, Shalaby IM.
    J Helminthol; 1990 Mar; 64(1):62-4. PubMed ID: 2110944
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R, Pinto PL, de Sant'Ana EJ, Moreira AA, Amato Neto V.
    Rev Hosp Clin Fac Med Sao Paulo; 1987 Mar; 42(5):201-3. PubMed ID: 3135570
    [No Abstract] [Full Text] [Related]

  • 27. Tolerance of Kenyan Schistosoma mansoni to oxamniquine.
    Coles GC, Mutahi WT, Kinoti GK, Bruce JI, Katz N.
    Trans R Soc Trop Med Hyg; 1987 Mar; 81(5):782-5. PubMed ID: 3130689
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment.
    Katz N, Rocha RS, de Souza CP, Coura Filho P, Bruce JI, Coles GC, Kinoti GK.
    Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880
    [Abstract] [Full Text] [Related]

  • 29. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N, Rocha RS, Lambertucci JR, Greco DB, Pedroso ER, Rocha MO, Flan S.
    Rev Inst Med Trop Sao Paulo; 1983 May; 25(4):173-7. PubMed ID: 6361966
    [No Abstract] [Full Text] [Related]

  • 30. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N, Rocha RS.
    Rev Inst Med Trop Sao Paulo; 1982 May; 24(5):310-4. PubMed ID: 6762634
    [No Abstract] [Full Text] [Related]

  • 31. Repeated community-based chemotherapy for the control of Schistosoma mansoni: effect of screening and selective treatment on prevalences and intensities of infection.
    Gryseels B, Nkulikyinka L, Engels D.
    Am J Trop Med Hyg; 1991 Oct; 45(4):509-17. PubMed ID: 1951860
    [Abstract] [Full Text] [Related]

  • 32. Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni.
    Gryseels B, Nkulikyinka L, Engels D.
    Am J Trop Med Hyg; 1994 Nov; 51(5):634-41. PubMed ID: 7985756
    [Abstract] [Full Text] [Related]

  • 33. Double-blind therapeutical evaluation based on the quantitative oogram technique, comparing praziquantel and oxamniquine in human schistosomiasis mansoni.
    da Cunha AS, Pedrosa RC.
    Rev Inst Med Trop Sao Paulo; 1986 Nov; 28(5):337-51. PubMed ID: 3109000
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of patients with schistosomiasis mansoni: a double blind clinical trial comparing praziquantel with oxamniquine.
    da Silva LC, Zeitune JM, Rosa-Eid LM, Lima DM, Antonelli RH, Christo CH, Saez-Alquezar A, Carboni Ade C.
    Rev Inst Med Trop Sao Paulo; 1986 Nov; 28(3):174-80. PubMed ID: 3103198
    [No Abstract] [Full Text] [Related]

  • 35. Immuno-epidemiology of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B, Stelma F, Talla I, Polman K, Van Dam G, Sow S, Diaw M, Sturrock RF, Decam C, Niang M.
    Mem Inst Oswaldo Cruz; 1995 Nov; 90(2):271-6. PubMed ID: 8531670
    [Abstract] [Full Text] [Related]

  • 36. Treatment of schistosomiasis mansoni with oxamniquine--five years' experience.
    Kilpatrick ME, Farid Z, Bassily S, El-Masry NA, Trabolsi B, Watten RH.
    Am J Trop Med Hyg; 1981 Nov; 30(6):1219-22. PubMed ID: 7325280
    [Abstract] [Full Text] [Related]

  • 37. Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. I. Parasitological effects and morbidity.
    Kloetzel K, Schuster NH.
    Trans R Soc Trop Med Hyg; 1987 Nov; 81(3):365-70. PubMed ID: 3120363
    [Abstract] [Full Text] [Related]

  • 38. Oxamniquine for treating Schistosoma mansoni infection in Sudan.
    Omer AH.
    Br Med J; 1978 Jul 15; 2(6131):163-5. PubMed ID: 678831
    [Abstract] [Full Text] [Related]

  • 39. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
    Lambertucci JR, Modha J, Curtis R, Doenhoff M.
    Trans R Soc Trop Med Hyg; 1989 Jul 15; 83(3):354-7. PubMed ID: 2515622
    [Abstract] [Full Text] [Related]

  • 40. A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi.
    Carabin H, Guyatt H, Engels D.
    Trop Med Int Health; 2000 Mar 15; 5(3):192-202. PubMed ID: 10747282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.